openPR Logo
Press release

Pharmacogenomics Market 2027 Top Key Companies – Assurex Health Inc., Illumina Inc., GeneDX, Pathway Genomics, Genetech

10-06-2017 04:05 PM CET | Health & Medicine

Press release from: Market Research Future

Pharmacogenomics Market 2027 Top Key Companies – Assurex

Market Research Future adds new report of “Global Pharmacogenomics Market Research Report - Forecast to 2027” it contains Company information, geographical data and Table of Content

Competitive Analysis:

The key players that are involved in global pharmacogenomics market Myriad

• Genetics Inc. (U.s)
• Transgenomic Inc. (U.s)
• 23andMe (U.S)
• Pathway Genomics (CA)
• Genetech (CA)
• GeneDX (U.S)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Illumina, Inc. (U.s),
• Assurex Health Inc. (U.s)

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1177

Market Segments

The market for pharmacogenomics is segmented into mainly three; by application, by therapeutic application, by end user and its various sub-segments.

• By Application include drug safety, Tailor treatments, drug discovery

• By Therapeutic Application Include cancer, oncology, cardiovascular

• By Methods include haplotype analysis, multivariate techniques, quantitative trait analysis

Market Highlight:

Globally the market for pharmacogenomics is increasing rapidly mainly due to increasing safety in drug. The factors that influence the growth of Pharmacogenomics market; rising utilization in medication revelation processes, increasing interest for customized drugs, expanding security in treatment, Improve evidence of guideline for adequacy trials. Globally the market for pharmacogenomics is expected to grow at the rate of about CAGR from 2016 to 2027.

Brief TOC

1. Report Prologue
2. Market Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
6. Global Pharmacogenomics Market, By Application
7. Global Pharmacogenomics Market, By Therapeutic Application
8. Global Pharmacogenomics Market, By Methods
9. Global Pharmacogenomics Market, By Region
10. Company Profile
11. Conclusion
12. Appendix

Browse Report Details @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market

Regional Analysis of Pharmacogenomics

North America dominated the global pharmacogenomics market with the largest market share, accounting for million and is expected to grow over billion by 2027. The European market for Pharmacogenomics is expected to grow at GAGR (2016-2027). Asia-Pacific is expected to grow at CAGR from million in 2016 to million by 2027.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market 2027 Top Key Companies – Assurex Health Inc., Illumina Inc., GeneDX, Pathway Genomics, Genetech here

News-ID: 760846 • Views:

More Releases from Market Research Future

Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CAGR | MRFR
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services. Market Overview and Growth Trends As per Market
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Companies - Oticon, Demant, Eargo, GN Store Nord
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Compa …
The Hearing Aids Market is experiencing consistent growth as the prevalence of hearing loss increases among both aging and younger populations exposed to noise-related hearing issues. Hearing aids play a critical role in enhancing communication, social interaction, and overall quality of life for individuals with hearing impairment. Advances in digital technology, wireless connectivity, and user-centric designs are further boosting adoption worldwide. Market Overview and Growth Trends As per Market Research Future Analysis,
Free Space Optic Communication Market Size to Soar to USD 10,667.18 Billion by 2035 with Rapid Technological Adoption
Free Space Optic Communication Market Size to Soar to USD 10,667.18 Billion by 2 …
The Free Space Optic Communication Market report provides comprehensive insights into market trends, competitive landscape, growth factors, and opportunities across global regions. Free Space Optic Communication Market Overview The Free Space Optic (FSO) Communication Market is witnessing unprecedented growth due to the increasing demand for high-speed, secure, and wireless optical communication solutions. FSO technology uses light to transmit data through free space, offering advantages over traditional fiber-optic and radio frequency communications, particularly
Desiccant Dehumidifier Market Size to Reach USD 1,181.09 Million by 2035 Driven by Industrial and Commercial Demand
Desiccant Dehumidifier Market Size to Reach USD 1,181.09 Million by 2035 Driven …
The Desiccant Dehumidifier Market report provides detailed insights into market trends, competitive landscape, growth factors, and opportunities across global regions. Desiccant Dehumidifier Market Overview The Desiccant Dehumidifier Market is witnessing steady growth due to increasing demand for moisture control in industrial, commercial, and specialized environments. Desiccant dehumidifiers utilize hygroscopic materials to absorb moisture efficiently, making them ideal for low-temperature operations, pharmaceuticals, food processing, and manufacturing facilities. The Desiccant Dehumidifier Market Size was

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Pharmacogenomics Market are: • F. Hoffmann-la Roche Ltd • Abbott • Oxford Nanopore Technologies • Thermo Fisher Scientific Inc. • Illumina, Inc. • QIAGEN • Agilent Technologies, Inc. • Myriad Genetics, Inc. • Admera Health Contact Us: If you have any queries about
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market. Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period. Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776 The pharmacogenomics market is segmented on the basis of
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy. These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain